ScentTECH Ltd Competitors

ScentAir Technologies, LLC., privately held and founded in 1994, provides best-in-class ambient scent marketing solutions to many of the world’s most recognized brands. As the global leader in olfactory marketing, the Company creates memorable impressions for both small businesses and global enterprises, elevating their customer experience through the power of scent. Based in Charlotte, NC, USA, and corporate offices in the United Kingdom, France, Netherlands, China, Hong Kong, and Australia. The Company’s 500+ global team members service customers in 119 countries through its dedicated global supply chain and manufacturing operations in North America, Europe, and Asia. ScentAir is committed to the creation of customized scent strategies that boost clients’ brand sentiments, customer loyalty, and sales.

Prolitec® is a global leader in ambient scenting and multisensory experience design. We develop patented scent diffusion technologies and custom fragrance programs that enhance customer experience across hospitality, retail, and high-traffic environments. Using scent as a medium of communication, we help brands elevate: guest experience in luxury and lifestyle hospitality, in-store experience for retail and fashion, brand identity through signature scents, well-being through aromatherapy solutions, air quality through advanced odor remediation technologies. Our AirQ™ platform delivers uniform, hypoallergenic, and ultra-precise diffusion for consistent, high-quality results. Today, Prolitec powers more than 100,000 installations in 83 countries — shaping how millions of people experience spaces every day. Prolitec is also the parent company of Aera, bringing the same expertise in fragrance innovation to homes worldwide. www.aeraforhome.com Specialties: ambient scenting, scent marketing, multisensory customer experience, fragrance technology, experiential marketing, odor remediation, commercial air care, luxury hospitality scenting, retail experience design, and environmental scent systems.

Launched in the U.S. in 2023, NuvoAir is an integrated specialty care platform transforming how complex cardiopulmonary patients are treated. We focus on preventing and managing exacerbations, major drivers of healthcare costs, while providing ongoing, high-quality care. Our platform supports physicians by preserving their autonomy, improving patient outcomes, and unlocking new revenue opportunities. Through partnerships with health plans, risk-bearing groups, and forward-thinking cardiologists and pulmonologists, we are redefining care for people with serious heart and lung conditions. To discover more about how NuvoAir is advancing high-value care in the cardiopulmonary space and to explore NuvoAir's extensive body of clinical evidence, visit nuvoair.com.